Genelux Corporation (GNLX) Key Metrics
GNLX valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $109.5M
- Enterprise value
- $97.3M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- —
- Price / book
- 7.0 10-yr median 14.0
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 0.58
GNLX key metrics, 2019–2025
Fiscal year ended December 31, 2025 · U.S. dollarsGNLX valuation Price multiples at each fiscal year-end price.
GNLX returns How much profit the business earns on the capital it uses.
GNLX per-share figures Results divided by the shares outstanding at year-end.
GNLX financial health Debt, liquidity and how easily interest is covered.
GNLX efficiency & capital use Working capital cycle and where the cash goes.
GNLX valuation history
GNLX returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
GNLX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
GNLX price vs earnings per share
GNLX key metrics
2019–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Valuation | |||||||
| Market capitalization | $162.1M | $74.2M | $342.3M | — | — | — | — |
| Enterprise value | $149.2M | $45.2M | $321.6M | — | — | — | — |
| Price / book | 14.0 | 2.8 | 17.6 | — | — | — | — |
| Earnings yield | −19.8% | −40.2% | −8.3% | — | — | — | — |
| Free cash flow yield | −16.3% | −29.1% | −6.2% | — | — | — | — |
| Share price at fiscal year-end | $4.36 | $2.36 | $14.01 | — | — | — | — |
| Per share | |||||||
| Revenue per share | $0.00 | $0.00 | $0.01 | $0.45 | $0.00 | $0.00 | $0.00 |
| Earnings per share | −$0.86 | −$0.95 | −$1.16 | −$0.21 | −$0.75 | −$0.63 | −$0.49 |
| Operating cash flow per share | −$0.68 | −$0.67 | −$0.83 | −$0.15 | −$0.28 | −$0.31 | −$0.31 |
| Free cash flow per share | −$0.71 | −$0.69 | −$0.87 | −$0.15 | −$0.28 | −$0.31 | −$0.38 |
| Cash per share | $0.39 | $0.98 | $0.95 | $0.02 | $0.19 | $0.48 | $0.02 |
| Book value per share | $0.31 | $0.84 | $0.80 | −$1.46 | −$1.40 | −$0.96 | −$1.05 |
| Tangible book value per share | $0.31 | $0.84 | $0.80 | −$1.46 | −$1.40 | −$0.96 | −$1.05 |
| Capex per share | $0.03 | $0.01 | $0.04 | $0.00 | $0.00 | $0.00 | $0.07 |
| Debt per share | $0.05 | $0.06 | $0.10 | $1.07 | $1.07 | $1.10 | $0.76 |
| Shares outstanding | 37.2M | 31.5M | 24.4M | 24.6M | 23.6M | 23.6M | 23.6M |
| Change in shares outstanding | +18.2% | +28.7% | −0.5% | +4.0% | 0.0% | 0.0% | — |
| Returns & profitability | |||||||
| Return on equity (ROE) | −170.0% | −130.6% | — | — | — | — | — |
| Return on assets (ROA) | −119.6% | −95.4% | −169.3% | −76.3% | −160.8% | −171.9% | −354.5% |
| Return on tangible assets | −168.9% | −86.0% | −101.4% | −94.1% | −219.0% | −106.1% | −354.5% |
| Free cash flow margin | — | — | — | −32.7% | — | — | — |
| Financial health | |||||||
| Total debt | $1.7M | $1.9M | $2.5M | $26.4M | $25.3M | $26.1M | $18.0M |
| Cash & short-term investments | $14.6M | $30.9M | $23.2M | $397,000 | $4.5M | $11.3M | $425,000 |
| Net debt | −$12.9M | −$29.0M | −$20.7M | $26.0M | $20.8M | $14.7M | $17.5M |
| Debt / equity | 0.15 | 0.07 | 0.13 | — | — | — | — |
| Debt / assets | 0.09 | 0.05 | 0.09 | 4.76 | 3.11 | 1.86 | 5.48 |
| Current ratio | 2.43 | 4.57 | 3.69 | 0.06 | 0.26 | 0.79 | 0.04 |
| Quick ratio | 2.43 | 4.57 | 3.69 | 0.06 | 0.26 | 0.79 | 0.04 |
| Interest coverage | — | — | -6.1 | -2.1 | -8.1 | -10.2 | -14.3 |
| Working capital | $8.9M | $24.6M | $17.6M | −$29.7M | −$16.7M | −$3.0M | −$14.2M |
| Invested capital | −$1.4M | −$2.8M | −$1.2M | −$9.8M | −$12.3M | −$7.9M | −$7.3M |
| Tangible asset value | $11.5M | $26.3M | $19.5M | −$35.8M | −$33.1M | −$22.7M | −$24.8M |
| Net current asset value | $7.6M | $23.1M | $15.8M | −$39.4M | −$35.4M | −$25.2M | −$27.5M |
| Graham net-net per share | $0.19 | $0.71 | $0.60 | −$1.67 | −$1.56 | −$1.07 | −$1.17 |
| Capital allocation | |||||||
| Capex / revenue | 13,725.0% | 4,762.5% | 602.9% | 0.4% | — | — | — |
| Capex / depreciation | 1.91 | 0.42 | 1.01 | 0.05 | 0.05 | 0.03 | 3.71 |
| Stock-based compensation / revenue | 73,387.5% | 75,875.0% | 3,061.2% | 21.8% | — | — | — |
| R&D / revenue | 248,137.5% | 237,475.0% | 7,510.0% | 82.0% | — | — | — |
| SG&A / revenue | 167,137.5% | 158,825.0% | 6,804.7% | 45.2% | — | — | — |
| Efficiency | |||||||
| Days payables outstanding | 3,156.6 | 1,890.5 | 1,892.9 | 2,118.5 | 1,098.9 | 1,265.0 | 2,780.7 |
| Payables turnover | 0.12 | 0.19 | 0.19 | 0.17 | 0.33 | 0.29 | 0.13 |
| Asset turnover | 0.00 | 0.00 | 0.01 | 1.62 | 0.00 | 0.00 | 0.00 |
| Average payables | $5.0M | $4.7M | $5.3M | $5.6M | $2.7M | $2.3M | $3.6M |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from GNLX's annual financial statements (latest annual report filed March 19, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
GNLX valuation and financial ratios
Genelux earned a return on equity of −170.0% in fiscal 2025. It ended the year with $1.7 million of debt and $14.6 million in cash and short-term investments, a net cash position of $12.9 million. The share count rose 57.4% from 23.6M to 37.2M over 6 years.
See the GNLX income statement, the GNLX chart for price history, or the GNLX stock overview for the latest quote and news.
GNLX key metrics FAQ
What is Genelux's return on equity?
Genelux's return on equity (ROE) was −170.0% in fiscal 2025: net income of -$32.1 million on average shareholders' equity of $18.9 million.
How much debt does Genelux have?
Genelux had total debt of $1.7 million at the end of fiscal 2025, a debt-to-equity ratio of 0.15 and more cash than debt.
What is Genelux's free cash flow yield?
Genelux generated -$26.4 million of free cash flow in fiscal 2025, a free cash flow yield of −16.3% on its market value at year-end ($162.1 million).
What is Genelux's current ratio?
Genelux's current ratio was 2.43 at the end of fiscal 2025: current assets were 2.43 times current liabilities.